Quality control for digital mammography: Part II recommendations from the ACRIN DMIST trial

Martin J. Yaffe, Aili K. Bloomquist, Gordon E. Mawdsley, Etta D. Pisano, R. Edward Hendrick, Laurie L. Fajardo, John M. Boone, Kalpana Kanal, Mahadevappa Mahesh, Richard C. Fleischman, Joseph Och, Mark B. Williams, Daniel J. Beideck, Andrew D.A. Maidment

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

The Digital Mammography Imaging Screening Trial (DMIST), conducted under the auspices of the American College of Radiology Imaging Network (ACRIN), is a clinical trial designed to compare the accuracy of digital versus screen-film mammography in a screening population [E. Pisano, ACRIN 6652-Digital vs. Screen-Film Mammography, ACRIN (2001)]. Part I of this work described the Quality Control program developed to ensure consistency and optimal operation of the digital equipment. For many of the tests, there were no failures during the 24 months imaging was performed in DMIST. When systems failed, they generally did so suddenly rather than through gradual deterioration of performance. In this part, the utility and effectiveness of those tests are considered. This suggests that after verification of proper operation, routine extensive testing would be of minimal value. A recommended set of tests is presented including additional and improved tests, which we believe meet the intent and spirit of the Mammography Quality Standards Act regulations to ensure that full-field digital mammography systems are functioning correctly, and consistently producing mammograms of excellent image quality.

Original languageEnglish (US)
Pages (from-to)737-752
Number of pages16
JournalMedical physics
Volume33
Issue number3
DOIs
StatePublished - Mar 2006

Keywords

  • Digital mammography
  • Image quality
  • Quality control

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Quality control for digital mammography: Part II recommendations from the ACRIN DMIST trial'. Together they form a unique fingerprint.

Cite this